28/05-2019 15:45:11: (NAVA) Navamedic ASA: Annual General Meeting held

Navamedic ASA has today, 28 May 2019, held an annual general meeting. All
resolutions were made in accordance with the board's/nomination committee's
proposals. The minutes from the general meeting is attached hereto and will be
made available at www.navamedic.com.

For further information please contact:

Toril Ås, Chief Financial Officer
E-mail: toril.as@navamedic.com
Phone +47 95 70 10 71

28/05-2019 16:48:12: (NAVA) Navamedic ASA: Expands Imdur® distribution to Greece
Oslo, 9 May 2019 - Navamedic ASA (OSE: NAVA) today announced it is expanding
distribution of the angina prevention medicine, Imdur®, to Greece, bringing the
distribution to a total of 14 markets across Europe.

"It is a pleasure to announce that Navamedic is expanding its distribution of
Imdur to Greece from the end of April. Imdur is part of a strategic partnership
with TopRidge Pharma Limited, under which the product has become Navamedic's
largest single brand. Although the generic competition has increased over the
last years, the product is highly important for our customers and for Navamedic.
The Greek market is expected to contribute to annual sales exceeding NOK eight
million," says Kathrine Gamborg Andreassen, Chief Executive Officer of
Navamedic.

Imdur® (isosorbide mononitrate), a prescription pharmaceutical used for
prevention of angina pectoris due to heart disease, was first launched in Europe
in 1985. Navamedic commenced distribution of the product as part of a strategic
partnership and long-term distribution agreement with TopRidge Pharma Limited in
2016.

"Market expansion for existing products is key to Navamedic's growth strategy,
in addition to launching new products in our territories. With the launch of
Imdur in the Greek market, we have extended our marketing and distribution
platform with the capability to add future products in this interesting market,"
Gamborg Andreassen concludes.

Navamedic viser frem sitt store potensiale på SMB 2019:


Den store selskapskvelden – SMB 2019

21. mai 2019, Oslo Børs og AksjeNorge gjentar suksessen fra i fjor, og har gleden av å invitere deg til Den store selskapskvelden – SMB 2019. Benytt anledningen til å bli kjent med noen av de mindre og mellomstore selskapene på Oslo Børs ved å høre dem presentere seg og med muligheten til å møte representanter fra selskapene.

I tillegg til selskapspresentasjoner vil DNB Markets, ODIN Forvaltning og flere holde dagsaktuelle innlegg. Hvert enkelt innlegg avsluttes med deres beste aksjetips akkurat nå. Du vil også møte dem i mingleområdet.

Selskapene du møter på scenen og i mingleområdet denne kvelden er:

NEL, ADS Crude Carriers, Gentian Diagnostics, Webstep, Navamedic, Okeanis Eco Tankers, Zwipe og PCI Biotech Holding

Dette er en ypperlig anledning å høre direkte fra selskapene selv hva som blir de viktige driverne fremover, i tillegg til at vi lærer mer om selskapene.

Påmelding:
Arrangementet er gratis og det tilbys enkel bevertning. I fjor fikk vi 700 påmeldinger så vær rask.

http://aksjenorge.no/aktuelt/2019/05/21/aksjekveld4juni/

Liker denne:
we have extended our marketing and distribution
platform with the capability to add future products in this interesting market,"

Hellas er ett stort marked, så får vi se om Nava har andre produkter klare for salg der.